Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GNC Eyes Possible IPO, Reports 14% Revenue Growth

This article was originally published in The Tan Sheet

Executive Summary

GNC Corp. reported a 14% increase in third-quarter revenues to $367.7 mil., but the nutritional supplement chain's parent holding company said it is considering selling GNC or conducting an initial public offering to increase its value to investors

You may also be interested in...



GNC To Be Acquired For $1.65 Bil. By Ares, Ontario Teachers’ Pension Plan

Ares Management and the Ontario Teachers' Pension Plan private investment groups have agreed to purchase the parent company of vitamin and nutritional supplement firm GNC for $1.65 billion, the firms announce Feb. 9

GNC To Be Acquired For $1.65 Bil. By Ares, Ontario Teachers’ Pension Plan

Ares Management and the Ontario Teachers' Pension Plan private investment groups have agreed to purchase the parent company of vitamin and nutritional supplement firm GNC for $1.65 billion, the firms announce Feb. 9

GNC To Be Acquired For $1.65 Bil. By Ares, Ontario Teachers’ Pension Plan

Ares Management and the Ontario Teachers' Pension Plan private investment groups have agreed to purchase the parent company of vitamin and nutritional supplement firm GNC for $1.65 billion, the firms announce Feb. 9

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS099944

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel